Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Torrent Pharmaceuticals Ltd
Operating Income
Torrent Pharmaceuticals Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹24.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹64.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹52.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹101.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
5%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Income
₹45.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Operating Income
₹21.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Torrent Pharmaceuticals Ltd's Operating Income?
Operating Income
24.1B
INR
Based on the financial report for Dec 31, 2023, Torrent Pharmaceuticals Ltd's Operating Income amounts to 24.1B INR.
What is Torrent Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was 21%. The average annual Operating Income growth rates for Torrent Pharmaceuticals Ltd have been 10% over the past three years , 14% over the past five years , and 13% over the past ten years .